In common with global trends, the number of individuals with Type 2 diabetes in the UK is rising, driven largely by obesity. The increasing prevalence of younger individuals with type 2 diabetes is of particular concern, due to the accelerated course of diabetes-related complications that is observed in this population. The importance of good glycaemic control in the prevention of microvascular complications of diabetes is widely accepted and there is a growing body of evidence to support a benefit in the reduction of cardiovascular events in the long-term. Despite the importance of maintaining a healthy weight for the prevention of type 2 diabetes; the results from trials of lifestyle intervention strategies to reduce body weight have been disappointing. New glucose-lowering agents offer some promise in this regard, offering an opportunity to combat the dual burden of hyperglycaemia and obesity simultaneously. The timing and appropriate choice of glucose lowering therapy has never been more complex owing to rising prevalence in the young, concomitant obesity in some 90% of adults with type 2 diabetes and an ever increasing range of therapeutic options. The present review evaluates performance measures specific to weight and glycaemic control in type 2 diabetes in the UK using data from the Quality and Outcomes Framework in England and Wales, and Scottish Diabetes Survey. Potential barriers to improvement in standards of care for people with type 2 diabetes are considered, including patient factors, clinical inertia and the difficulties in translating therapeutic guidelines into everyday clinical practice.
Pharmacology, Toxicology and Pharmaceutical Science
4
4%
Biochemistry, Genetics and Molecular Biology
2
2%
Agricultural and Biological Sciences
2
2%
Other
11
10%
Unknown
41
38%
Attention Score in Context
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 August 2016.
All research outputs
#21,431,531
of 34,410,798 outputs
Outputs from Diabetes, Obesity & Metabolism
#3,196
of 6,085 outputs
Outputs of similar age
#191,764
of 333,695 outputs
Outputs of similar age from Diabetes, Obesity & Metabolism
#41
of 65 outputs
Altmetric has tracked 34,410,798 research outputs across all sources so far. This one is in the 37th percentile – i.e., 37% of other outputs scored the same or lower than it.
So far Altmetric has tracked 6,085 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.6. This one is in the 46th percentile – i.e., 46% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 333,695 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 42nd percentile – i.e., 42% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 65 others from the same source and published within six weeks on either side of this one. This one is in the 36th percentile – i.e., 36% of its contemporaries scored the same or lower than it.
